|
1. Hirsch E, Graybiel AM, Agid YA. Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson's disease. Nature 1988; 334(6180): 345-8. 2. Khalaji H, Bahrami A, Noroozian M, Mohammadzadeh HS. The effect of physical activity on functional fitness and quality of life in people with Parkinson's disease. Med J Mashad Univ Med Sci 2014; 53(3): 524-54. 3. Levin J, Kurz A, Arzberger T, Giese A, Höglinger GU. The differential diagnosis and treatment of atypical parkinsonism. Dtsch Arztebl Int 2016; 113(5): 61. 4. Marrocco J, Mairesse J, Bucci D, Lionetto L, Battaglia G, Consolazione M, et al. Early life stress causes refractoriness to haloperidol-induced catalepsy. Mol Pharmacol 2013; 84(2): 244-51. 5. Sanberg PR, Bunsey MD, Giordano M, Norman AB. The catalepsy test: its ups and downs. BehavNeurosci 1988; 102(5): 748. 6. Dauer W, Przedborski S. Parkinson's disease: mechanisms and models. Neuron 2003; 39(6): 889-909. 7. Kim HJ, Jeon BS, Paek SH. Effect of deep brain stimulation on pain in Parkinson disease. J Neurol Sci 2011; 310(1-2): 251-5. 8. Hu G, Jousilahti P, Bidel S, Antikainen R, Tuomilehto J. Type 2 diabetes and the risk of Parkinson's disease. Diabetes Care 2007; 30(4): 842-7. 9. Arvanitakis Z, Wilson RS, Bienias JL, Bennett DA. Diabetes and parkinsonian signs in older persons. Alzheimer Dis Assoc Disord 2007; 21(2): 144-9. 10. Santiago JA, Potashkin JA. Shared dysregulated pathways lead to Parkinson's disease and diabetes. Trends Mol Med 2013; 19(3): 176-86. 11. Laaksonen DE, Atalay M, Niskanen LK, Mustonen J, Sen CK, Lakka TA, et al. Aerobic exercise and the lipid profile in type 1 diabetic men: a randomized controlled trial. Med Sci Sports Exerc 2000; 32(9): 1541-8. 12. American Diabetes Association. Physical activity/exercise and diabetes. Diabetes Care 2004; 27(suppl 1): s58-s62. 13. Adlard PA, Perreau VM, Cotman CW. The exercise-induced expression of BDNF within the hippocampus varies across life-span. Neurobiol Aging 2005; 26(4): 511-20. 14. Atalay M, Laaksonen DE. Diabetes, oxidative stress and physical exercise. Med Sci Sports Exerc 2002; 1(1): 1-14. 15. Fishman PS, Gass JS, Swoveland PT, Lavi E, Highkin MK, Weiss SR. Infection of the basal ganglia by a murine coronavirus. Science 1985; 229(4716): 877-9. 16. Kleim JA, Cooper NR, VandenBerg PM. Exercise induces angiogenesis but does not alter movement representations within rat motor cortex. Brain Res 2002; 934(1): 1-6. 17. Swain RA, Harris AB, Wiener EC, Dutka MV, Morris HD, Theien BE, et al. Prolonged exercise induces angiogenesis and increases cerebral blood volume in primary motor cortex of the rat. Neuroscience 2003; 117(4): 1037-46. 18. Tillerson JL, Caudle WM, Reveron ME, Miller GW. Exercise induces behavioral recovery and attenuates neurochemical deficits in rodent models of Parkinson's disease. Neuroscience 2003; 119(3): 899-911. 19. Van Praag H, Christie BR, Sejnowski TJ, Gage FH. Running enhances neurogenesis, learning, and long-term potentiation in mice. Proc Natl Acad Sci U S A 1999; 96(23): 13427-31. 20. Pushparaj P, Tan C, Tan B. Effects of Averrhoa bilimbi leaf extract on blood glucose and lipids in streptozotocin-diabetic rats. J Ethnopharmacol 2000; 72(1-2): 69-76. 21. Baydas G, Nedzvetskii VS, Nerush PA, Kirichenko SV, Yoldas T. Altered expression of NCAM in hippocampus and cortex may underlie memory and learning deficits in rats with streptozotocin-induced diabetes mellitus. Life Sci 2003; 73(15): 1907-16. 22. Murray DK, Sacheli MA, Eng JJ, Stoessl AJ. The effects of exercise on cognition in Parkinson’s disease: a systematic review. Transl Neurodegener 2014; 3(1): 5. 23. Toy WA, Petzinger GM, Leyshon BJ, Akopian GK, Walsh JP, Hoffman MV, et al. Treadmill exercise reverses dendritic spine loss in direct and indirect striatal medium spiny neurons in the 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP) mouse model of Parkinson's disease. Neurobiol Dis 2014; 63: 201-9. 24. Singh A, Naidu PS, Kulkarni SK. FK506 as effective adjunct to L-dopa in reserpine-induced catalepsy in rats. Indian J Exp Biol 2003; 41(11): 1264-8. 25. Colpaert FC. Pharmacological characteristics of tremor, rigidity and hypokinesia induced by reserpine in rat. Neuropharmacology 1987; 26(9): 1431-40. 26. Gerlach M, Riederer P. Animal models of Parkinson's disease: an empirical comparison with the phenomenology of the disease in man. J Neural Transm (Vienna) 1996; 103(8-9): 987-1041. 27. Fernandes VS, Santos JR, Leão AH, Medeiros AM, Melo TG, Izídio GS, et al. Repeated treatment with a low dose of reserpine as a progressive model of Parkinson's disease. Behav Brain Res 2012; 231(1): 154-63. 28. Stern MB. Parkinson's disease: early diagnosis and management. J Fam Pract 1993; 36(4): 439-46. 29. Mabandla MV, Russell VA. Voluntary exercise reduces the neurotoxic effects of 6-hydroxydopamine in maternally separated rats. Behav Brain Res 2010; 211(1): 16-22. 30. Yoon MC, Shin MS, Kim TS, Kim BK, Ko IG, Sung YH, et al. Treadmill exercise suppresses nigrostriatal dopaminergic neuronal loss in 6-hydroxydopamine-induced Parkinson's rats. Neurosci Lett 2007; 423(1): 12-7. 31. Howells FM, Russell VA, Mabandla MV, Kellaway LA. Stress reduces the neuroprotective effect of exercise in a rat model for Parkinson's disease. Behav Brain Res 2005; 165(2): 210-20. 32. Tajiri N, Yasuhara T, Shingo T, Kondo A, Yuan W, Kadota T, et al. Exercise exerts neuroprotective effects on Parkinson's disease model of rats. Brain Res 2010; 1310: 200-7. 33. Hashimoto K, Shimizu E, Iyo M. Critical role of brain-derived neurotrophic factor in mood disorders. Brain Res Brain Res Rev 2004; 45(2): 104-14. 34. Kones R. Parkinson’s disease: mitochondrial molecular pathology, inflammation, statins, and therapeutic neuroprotective nutrition. Nutr Clin Pract 2010; 25(4): 371-89. 35. Boström P, Wu J, Jedrychowski MP, Korde A, Ye L, Lo JC, et al. A PGC1-alpha-dependent myokine that drives brown-fat-like development of white fat and thermogenesis. Nature 2012; 481(7382): 463-8. 36. Spiegelman BM. Banting Lecture 2012 Regulation of adipogenesis: toward new therapeutics for metabolic disease. Diabetes 2013; 62(6): 1774-82. 37. Erickson KI, Weinstein AM, Lopez OL. Physical activity, brain plasticity, and Alzheimer's disease. Arch Med Res 2012; 43(8): 615-21. 38. Novelle MG, Contreras C, Romero-Picó A, López M, Diéguez C. Irisin, two years later. Int J Endocrinol 2013; 2013: 746281. 39. Harati Y. Diabetes and the nervous system. Endocrinol Metab Clin North Am 1996; 25(2): 325-59 . 40. Saller CF, Chiodo LA. Glucose suppresses basal firing and haloperidol-induced increases in the firing rate of central dopaminergic neurons. Science 1980; 210(4475): 1269-71. 41. Trulson ME, Himmel CD. Decreased Brain Dopamine Synthesis Rate and Increased [3H] Spiroperidol Binding in Streptozotocin‐Diabetic Rats. J Neurochem 1983; 40(5): 1456-9. 42. Xu Q, Park Y, Huang X, Hollenbeck A, Blair A, Schatzkin A, et al. Diabetes and risk of Parkinson’s disease. Diabetes Care 2011; 34(4): 910-5. 43. Craft S, Watson GS. Insulin and neurodegenerative disease: shared and specific mechanisms. Lancet Neurol 2004; 3(3): 169-78. 44. Gordon B, Benson A, Bird S, Fraser S. Resistance training improves metabolic health in type 2 diabetes: a systematic review. Diabetes Res Clin Pract 2009; 83(2): 157-75. 45. Henriksen EJ. Invited review: Effects of acute exercise and exercise training on insulin resistance. J Appl Physiol 2002; 93(2): 788-96. 46. Yuede CM, Zimmerman SD, Dong H, Kling MJ, Bero AW, Holtzman DM, et al. Effects of voluntary and forced exercise on plaque deposition, hippocampal volume, and behavior in the Tg2576 mouse model of Alzheimer's disease. Neurobiol Dis 2009; 35(3): 426-32.
|
.png)
.png){kind=logo}
